Overview
- Citing posts made on Monday, August 3, McGraw wrote on Instagram that three years of Ozempic use “brought back” a prior eating disorder and left her internal system permanently changed.
- She says the drug did help control PMOS/PCOS symptoms, but she later switched from Ozempic to a low dose of Mounjaro and is now off the weight-loss medication and recovering.
- McGraw described rapid weight loss as changing how people treated her and said new attention and more opportunities fed a return to disordered eating under what she called a renewed 'skinny culture.'
- She called taking Ozempic one of the worst choices she made for herself, said the experience harmed her mental health, and acknowledged she still has occasional body-image 'slip-ups.'
- The account adds to wider public discussion about GLP‑1 drugs: clinicians prescribe them for metabolic issues including PCOS, eating-disorder experts warn about mental-health risks tied to rapid medically assisted weight loss, and advocates such as NEDA offer resources for people in crisis.